[CH:1]1([NH:4][C:5]([C:7]2[N:8]=[N:9][N:10]([C:21]3[CH:26]=[CH:25][C:24]([C:27]([NH:29][CH2:30][CH3:31])=[O:28])=[CH:23][CH:22]=3)[C:11]=2[CH2:12]P(OCC)(OCC)=O)=[O:6])[CH2:3][CH2:2]1.[H-].[Na+].[CH:34]([C:36]1[S:37][CH:38]=[CH:39][N:40]=1)=O>C1COCC1>[CH:1]1([NH:4][C:5]([C:7]2[N:8]=[N:9][N:10]([C:21]3[CH:22]=[CH:23][C:24]([C:27]([NH:29][CH2:30][CH3:31])=[O:28])=[CH:25][CH:26]=3)[C:11]=2/[CH:12]=[CH:34]/[C:36]2[S:37][CH:38]=[CH:39][N:40]=2)=[O:6])[CH2:3][CH2:2]1To a suspension of N-cyclopropyl-5-(diethylphosphonomethyl)-1-{4-[(ethylamino)carbonyl]phenyl}-1H-1,2,3-triazole-4-carboxamide (340 mg) obtained in Example 321b) in THF (5 ml) was added sodium hydride (50% oil dispersion, 55 mg) at 0° C., and the mixture was stirred at room temperature for 30 min. A solution of 2-formylthiazole (86 mg) in THF (1 ml) was added to the obtained reaction mixture, and the mixture was stirred at room temperature for 2 hr. The resultant precipitate was collected by filtration to give the title compound as a white solid (149 mg).
불러오는 중…